Blood transfusions in patients with thalassemia or sickle cell anemia have been made safe by using CRISPR-Cas9 gene editing tool, finds a new study. from Medindia Health News https://ift.tt/2r5Syrz
No comments
Thanks for comment via will connect you within 24 hours.